166 related articles for article (PubMed ID: 17979991)
1. Inhibition of herpes simplex virus type 1 by small interfering RNA.
Zhang YQ; Lai W; Li H; Li G
Clin Exp Dermatol; 2008 Jan; 33(1):56-61. PubMed ID: 17979991
[TBL] [Abstract][Full Text] [Related]
2. Silencing herpes simplex virus type 1 capsid protein encoding genes by siRNA: a promising antiviral therapeutic approach.
Jin F; Li S; Zheng K; Zhuo C; Ma K; Chen M; Wang Q; Zhang P; Fan J; Ren Z; Wang Y
PLoS One; 2014; 9(5):e96623. PubMed ID: 24794394
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA targeting for infected-cell polypeptide 4 inhibits herpes simplex virus type 1 replication in retinal pigment epithelial cells.
Duan F; Ni S; Nie Y; Huang Q; Wu K
Clin Exp Ophthalmol; 2012 Mar; 40(2):195-204. PubMed ID: 21883773
[TBL] [Abstract][Full Text] [Related]
4. RNA interference inhibits herpes simplex virus type 1 isolated from saliva samples and mucocutaneous lesions.
Silva AP; Lopes JF; Paula VS
Braz J Infect Dis; 2014; 18(4):441-4. PubMed ID: 24835621
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated RNA interference against herpes simplex virus infection in vitro.
Chen L; Pan ZQ; Zhai CB
Folia Histochem Cytobiol; 2021; 59(4):302-310. PubMed ID: 34905214
[TBL] [Abstract][Full Text] [Related]
6. Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity.
Kalke K; Lehtinen J; Gnjatovic J; Lund LM; Nyman MC; Paavilainen H; Orpana J; Lasanen T; Frejborg F; Levanova AA; Vuorinen T; Poranen MM; Hukkanen V
Viruses; 2020 Dec; 12(12):. PubMed ID: 33322225
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated shRNA interference against HSV-1 replication in vitro.
Song B; Liu X; Wang Q; Zhang R; Yang T; Han Z; Xu Y
J Neurovirol; 2016 Dec; 22(6):799-807. PubMed ID: 27566181
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools.
Paavilainen H; Lehtinen J; Romanovskaya A; Nygårdas M; Bamford DH; Poranen MM; Hukkanen V
J Med Virol; 2016 Dec; 88(12):2196-2205. PubMed ID: 27191509
[TBL] [Abstract][Full Text] [Related]
9. Recombinant cell lines expressing shRNA targeting herpes simplex virus 2 VP16 inhibit virus replication.
Zhang R; Wang Y; Song B; Han ZQ; Xu YM
Intervirology; 2012; 55(6):426-34. PubMed ID: 22286011
[TBL] [Abstract][Full Text] [Related]
10. Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA.
Zhe R; Mei-Ying Z; Kitazato K; Kobayash N; Qin-Chang Z; Pei-Zhuo Z; Zhi-Rong Y; Yi-Fei W
Arch Virol; 2008; 153(7):1401-6. PubMed ID: 18551244
[TBL] [Abstract][Full Text] [Related]
11. Effect of black tea extract on herpes simplex virus-1 infection of cultured cells.
Cantatore A; Randall SD; Traum D; Adams SD
BMC Complement Altern Med; 2013 Jun; 13():139. PubMed ID: 23777309
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
13. Swarms of chemically modified antiviral siRNA targeting herpes simplex virus infection in human corneal epithelial cells.
Kalke K; Lund LM; Nyman MC; Levanova AA; Urtti A; Poranen MM; Hukkanen V; Paavilainen H
PLoS Pathog; 2022 Jul; 18(7):e1010688. PubMed ID: 35793357
[TBL] [Abstract][Full Text] [Related]
14. Effects of RNA interference therapy against herpes simplex virus type 1 encephalitis.
da Silva AS; Raposo JV; Pereira TC; Pinto MA; de Paula VS
Antivir Ther; 2016; 21(3):225-35. PubMed ID: 26669609
[TBL] [Abstract][Full Text] [Related]
15. Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes.
Bhuyan PK; Karikò K; Capodici J; Lubinski J; Hook LM; Friedman HM; Weissman D
J Virol; 2004 Oct; 78(19):10276-81. PubMed ID: 15367593
[TBL] [Abstract][Full Text] [Related]
16. Samarangenin B from Limonium sinense suppresses herpes simplex virus type 1 replication in Vero cells by regulation of viral macromolecular synthesis.
Kuo YC; Lin LC; Tsai WJ; Chou CJ; Kung SH; Ho YH
Antimicrob Agents Chemother; 2002 Sep; 46(9):2854-64. PubMed ID: 12183238
[TBL] [Abstract][Full Text] [Related]
17. Boswellia serrata oleo-gum-resin and β-boswellic acid inhibits HSV-1 infection in vitro through modulation of NF-кB and p38 MAP kinase signaling.
Goswami D; Mahapatra AD; Banerjee S; Kar A; Ojha D; Mukherjee PK; Chattopadhyay D
Phytomedicine; 2018 Dec; 51():94-103. PubMed ID: 30466633
[TBL] [Abstract][Full Text] [Related]
18. [EFFECTIVENESS OF POLYCATIONIC NANOPARTICLES OF POLYETHYLENEIMINE-POLYHYDROZIDE-CHITOSAN (PEI-PG-OCHG) AS A VECTOR FOR SMALL INTER- FERING RNA, DIRECTED TO SUPPRESS HERPES SIMPLEX TYPE 2 VIRUS REPLICATION].
Zh Mikrobiol Epidemiol Immunobiol; 2015; (3):31-7. PubMed ID: 26259267
[TBL] [Abstract][Full Text] [Related]
19. Short hairpin RNA-mediated inhibition of HSV-1 gene expression and function during HSV-1 infection in Vero cells.
Liu YY; Deng HY; Yang G; Jiang WL; Grossin L; Yang ZQ
Acta Pharmacol Sin; 2008 Aug; 29(8):975-82. PubMed ID: 18664330
[TBL] [Abstract][Full Text] [Related]
20. Vector derived artificial miRNA mediated inhibition of West Nile virus replication and protein expression.
Karothia D; Kumar Dash P; Parida M; Bhagyawant SS; Kumar JS
Gene; 2020 Mar; 729():144300. PubMed ID: 31884102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
